• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.

作者信息

Rose A S, Kuzma J W, Kurtzke J F, Namerow N S, Sibley W A, Tourtellotte W W

出版信息

Neurology. 1970 May;20(5):1-59. doi: 10.1212/wnl.20.5_part_2.1.

DOI:10.1212/wnl.20.5_part_2.1
PMID:4314823
Abstract
摘要

相似文献

1
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.多发性硬化症治疗评估的合作研究。促肾上腺皮质激素与安慰剂——最终报告。
Neurology. 1970 May;20(5):1-59. doi: 10.1212/wnl.20.5_part_2.1.
2
Cooperative study in the evaluation of therapy in multiple sclerosis; ACTH vs placebo in acute exacerbations. Preliminary report.
Neurology. 1968 Jun;18(6):Suppl:1-10. doi: 10.1212/wnl.18.6_part_2.1.
3
Neurologic impairment in multiple sclerosis and the disability status scale.多发性硬化症中的神经功能损害与残疾状态量表
Acta Neurol Scand. 1970;46(4):493-512. doi: 10.1111/j.1600-0404.1970.tb05808.x.
4
Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbation.
Trans Am Neurol Assoc. 1969;94:126-33.
5
Methodology for analyzing clinical neurological data: ACTH in multiple sclerosis.分析临床神经学数据的方法：多发性硬化症中的促肾上腺皮质激素
Clin Pharmacol Ther. 1978 Aug;24(2):146-53. doi: 10.1002/cpt1978242146.
6
Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.静脉注射甘露醇对多发性硬化症加重期的急性改善作用。
Ann Neurol. 1985 Oct;18(4):443-50. doi: 10.1002/ana.410180406.
7
The ocular manifestations of multiple sclerosis. 2. Abnormalities of eye movements.多发性硬化的眼部表现。2. 眼球运动异常。
J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):863-8. doi: 10.1136/jnnp.55.10.863.
8
Somatosensory far field potentials: studies in normal subjects and patients with multiple sclerosis.躯体感觉远场电位：对正常受试者和多发性硬化症患者的研究。
Electroencephalogr Clin Neurophysiol. 1978 Nov;45(5):602-10. doi: 10.1016/0013-4694(78)90160-8.
9
[Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
Neurol Neurochir Pol. 1988 Sep-Oct;22(5):399-403.
10
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.间歇性环磷酰胺脉冲疗法治疗进展型多发性硬化症：东北多发性硬化症协作治疗组的最终报告
Neurology. 1993 May;43(5):910-8. doi: 10.1212/wnl.43.5.910.

引用本文的文献

1
Off-Label Use vs Off-Label Marketing: Part 2: Off-Label Marketing-Consequences for Patients, Clinicians, and Researchers.药品未按批准用途使用与药品未按批准用途营销：第2部分：药品未按批准用途营销对患者、临床医生和研究人员的影响
JACC Basic Transl Sci. 2023 Mar 27;8(3):359-370. doi: 10.1016/j.jacbts.2022.12.012. eCollection 2023 Mar.
2
Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.多发性硬化症复发的诊断与治疗建议。
J Pers Med. 2021 Dec 22;12(1):6. doi: 10.3390/jpm12010006.
3
Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis.
美国为多发性硬化症急性加重期患者开具促肾上腺皮质激素注射液时保险拒付的后果
Neurol Ther. 2021 Jun;10(1):149-167. doi: 10.1007/s40120-020-00219-y. Epub 2020 Nov 10.
4
Melanocortin Regulation of Inflammation.黑素皮质素对炎症的调节
Front Endocrinol (Lausanne). 2019 Oct 9;10:683. doi: 10.3389/fendo.2019.00683. eCollection 2019.
5
Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials.多发性硬化急性复发治疗的疗效、安全性及生活质量：随机对照试验文献综述结果
Degener Neurol Neuromuscul Dis. 2019 Jul 1;9:55-78. doi: 10.2147/DNND.S208815. eCollection 2019.
6
Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients.波兰多发性硬化症患者的早期临床特征、二次进展时间和残疾里程碑。
Medicina (Kaunas). 2019 May 31;55(6):232. doi: 10.3390/medicina55060232.
7
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.向开具 Repository Corticotropin 处方的医师专家支付的行业款项。
JAMA Netw Open. 2018 Jun 1;1(2):e180482. doi: 10.1001/jamanetworkopen.2018.0482.
8
Assessment and Treatment Strategies for a Multiple Sclerosis Relapse.多发性硬化症复发的评估与治疗策略
J Immunol Clin Res. 2018;5(1). Epub 2016 Dec 7.
9
Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis.与多发性硬化症相关的环境因素的信号通路和治疗前景。
J Neurosci Res. 2018 Dec;96(12):1831-1846. doi: 10.1002/jnr.24322. Epub 2018 Sep 11.
10
Clinical trials in multiple sclerosis: milestones.多发性硬化症的临床试验：里程碑
Ther Adv Neurol Disord. 2018 Jul 9;11:1756286418785499. doi: 10.1177/1756286418785499. eCollection 2018.